Lawrence Lamb

CIK: 0001830059

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INAB

IN8BIO, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

INAB
IN8BIO, INC.
May 9, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
54K shares-
INAB
IN8BIO, INC.
Feb 4, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
72K shares-
INAB
IN8BIO, INC.
Apr 27, 2025
Award(A)
Series B Warrants (right to buy)
Direct
1.6K shares-
INAB
IN8BIO, INC.
Apr 27, 2025
Disposition(D)
Series B Warrants (right to buy)
Direct
1.6K shares-
INAB
IN8BIO, INC.
Feb 5, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
306.8K shares-
INAB
IN8BIO, INC.
Dec 19, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
286.9K shares-
INAB
IN8BIO, INC.
Sep 4, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
250K shares-

		Type	Shares	Price		Ownership
May 9, 2026	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	54,000	-	-	Direct
Feb 4, 2026	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	72,000	-	-	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Award(A) Series B Warrants (right to buy)	1,639	-	-	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Disposition(D) Series B Warrants (right to buy)	1,639	-	-	Direct
Feb 5, 2025	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	306,750	-	-	Direct
Dec 19, 2024	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	286,899	-	-	Direct
Sep 4, 2024	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	250,000	-	-	Direct

1-7 of 7 transactions

About Lamb Lawrence

Lamb Lawrence (SEC CIK 0001830059) files insider reports with the SEC as EVP and CSO of IN8BIO, INC. (INAB).

Signal8 holds 6 ownership filings by Lamb Lawrence, all Form 4s, filed between Sep 5, 2024 and May 12, 2026. Those filings report 7 transactions, from Sep 4, 2024 to May 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lamb Lawrence's filings is in NEW YORK, NY.

Recent filings by Lamb Lawrence

May 9, 2026: Grant or award of INAB derivative securities (Form 4, code A).
Feb 4, 2026: Grant or award of INAB derivative securities (Form 4, code A).
Apr 27, 2025: Grant or award of INAB derivative securities (Form 4, code A).
Apr 27, 2025: Disposition to issuer transaction of INAB derivative securities (Form 4, code D).
Feb 5, 2025: Grant or award of INAB derivative securities (Form 4, code A).

Other insiders filing for IN8BIO, INC. (INAB)

FAIRBAIRN EMILY, Director
Ho William Tai-Wei, CEO
Greenwood Luba, Director
McCall Patrick, CHIEF FINANCIAL OFFICER
Epperly Corinne, Director
Rochlin Kate, President and COO

How to read Form 4 transaction codes